Green Thumb Industries Inc. Stock

Equities

GTII

CA39342L1085

Drug Retailers

Market Closed - Canadian Securities Exchange 03:59:59 2024-04-18 pm EDT 5-day change 1st Jan Change
17.74 CAD 0.00% Intraday chart for Green Thumb Industries Inc. -7.99% +19.30%
Sales 2024 * 1.12B 1.54B Sales 2025 * 1.21B 1.66B Capitalization 3.06B 4.21B
Net income 2024 * 65M 89.43M Net income 2025 * 77M 106M EV / Sales 2024 * 3.02 x
Net Debt 2024 * 325M 447M Net Debt 2025 * 159M 218M EV / Sales 2025 * 2.66 x
P/E ratio 2024 *
47.5 x
P/E ratio 2025 *
40.5 x
Employees 4,561
Yield 2024 *
-
Yield 2025 *
-
Free-Float 78.03%
More Fundamentals * Assessed data
Dynamic Chart
Green Thumb Industries Insider Sold Shares Worth $258,256, According to a Recent SEC Filing MT
Green Thumb Industries Insider Sold Shares Worth $297,426, According to a Recent SEC Filing MT
Green Thumb Industries Insider Sold Shares Worth $298,536, According to a Recent SEC Filing MT
Cannabis Stocks Gain Following Rumors of Imminent Rescheduling DJ
Cannabis Stocks Retreat After WSJ Report of DEA Concerns DJ
Cannabis Shares Gain After Biden Says Marijuana Laws Should Be Loosened DJ
Green Thumb Industries Brief: Keeps Outperform Rating While 12-Month Price Target Raised To US$15 From $11 at Wedbush After "Strong" Q4 Results; Seen "Carrying on its Merry(land) Way" MT
Tranche Update on Green Thumb Industries Inc.'s Equity Buyback Plan announced on November 8, 2023. CI
Green Thumb Industries Inc. Provides earnings guidance for the first quarter 2024 CI
Transcript : Green Thumb Industries Inc., Q4 2023 Earnings Call, Feb 28, 2024
Green Thumb Industries Reports Fourth Quarter And Full Year 2023 Results MT
Green Thumb Industries Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2023 CI
Green Thumb Industries Brief: Q4 revenue of US$278 million increased 7% year-over-year; GAAP net income for Q4 of $3 million or $0.01 per basic and diluted share; Cash at quarter end of $162 Million MT
Earnings Flash (GTII.CN) GREEN THUMB INDUSTRIES Reports Q4 Revenue $278.2M MT
Green Thumb Industries Inc. announces an Increase in Equity Buyback. CI
More news
1 week-7.99%
Current month-10.58%
1 month-1.72%
3 months+5.78%
6 months+41.47%
Current year+19.30%
More quotes
1 week
16.75
Extreme 16.75
18.78
1 month
16.75
Extreme 16.75
20.74
Current year
14.08
Extreme 14.08
20.74
1 year
8.62
Extreme 8.62
20.74
3 years
8.62
Extreme 8.62
43.28
5 years
5.05
Extreme 5.05
49.66
10 years
5.05
Extreme 5.05
49.66
More quotes
Managers TitleAgeSince
Chief Executive Officer 45 02-02-17
Director of Finance/CFO 51 18-01-04
President 46 15-04-30
Members of the board TitleAgeSince
President 46 15-04-30
Director/Board Member 58 15-01-31
Chief Executive Officer 45 02-02-17
More insiders
Date Price Change Volume
24-04-18 17.74 -2.47% 25,586
24-04-17 18.19 +6.94% 131,554
24-04-16 17.01 -0.99% 54,873
24-04-15 17.18 -2.16% 79,951
24-04-12 17.56 -8.92% 141,973

Delayed Quote Canadian Securities Exchange, April 18, 2024 at 03:59 pm EDT

More quotes
Green Thumb Industries Inc. is a cannabis consumer packaged goods company. It is a retailer, which promotes well-being through the power of cannabis while giving back to the communities in which it serves. It has two segments: Retail and Consumer Packaged Goods. The Company owns, manufactures and distributes a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomons, Good Green, incredibles and RYTHM, to third-party retail stores across the United States, as well as to its own retail stores. It also owns and operates retail cannabis stores that include a national chain called RISE Dispensaries, as well as retail stores operating under other names. Its retail stores sell a combination of its products and third-party products. It operates in 14 United States markets, including California, Connecticut, Florida, Illinois, Maryland, Massachusetts, Minnesota, Nevada, New Jersey, New York, Ohio, Pennsylvania, Rhode Island and Virginia.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
D+
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
12.9 USD
Average target price
18.87 USD
Spread / Average Target
+46.27%
Consensus